Eplontersen sodium · Medicine question

What condition is Wainzua (eplontersen sodium) licensed to treat, and in which patients?

Name: What condition is Wainzua (eplontersen sodium) licensed to treat, and in which patients?
Published: 2026-11-08T01:29:02.168Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Wainzua (eplontersen sodium) is indicated to treat hereditary transthyretin-mediated amyloidosis (ATTRv amyloidosis) in adults with Stage 1 and 2 polyneuropathy.

Sources for this answer

Wainzua 45 mg solution for injection in pre-filled penAstraZeneca UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated 15 May 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about Eplontersen sodium